{"hands_on_practices": [{"introduction": "Before delving into the complex regulatory networks governing telomeres, it is essential to develop a quantitative intuition for their basic properties. This exercise [@problem_id:2609545] provides a foundational practice in translating the macroscopic measurement of telomere length, typically given in kilobase pairs ($kb$), into the microscopic reality of its constituent hexanucleotide repeats. By then modeling the inexorable shortening caused by the end-replication problem, you will build a concrete understanding of the scale and rate of telomere attrition, the fundamental challenge that all proliferating cells must address.", "problem": "A vertebrate telomere is composed of tandem repeats of the hexanucleotide sequence TTAGGG on the guanine-rich strand, forming a double-stranded tract whose length is commonly reported in kilobase pairs. Consider a chromosome end with a double-stranded telomere length of $10\\ \\mathrm{kb}$. Assume that each repeat contributes exactly $6$ base pairs to the double-stranded telomeric tract, that $1\\ \\mathrm{kb} = 10^{3}\\ \\mathrm{bp}$, and that subtelomeric sequence and the single-stranded $3^{\\prime}$ overhang can be neglected relative to the total length. In the absence of telomerase, the end-replication problem and end-processing progressively shorten the double-stranded telomere by an amount that varies from division to division; assume this per-division loss is independent and uniformly distributed between $50$ and $100$ base pairs.\n\nStarting from these assumptions and definitions, and without invoking any unmotivated shortcut formulas, do the following:\n- Compute the approximate number of TTAGGG repeats present in the $10\\ \\mathrm{kb}$ double-stranded telomere.\n- Estimate the expected number of cell divisions required to shorten the double-stranded telomere by $2\\ \\mathrm{kb}$, using the expected value of the specified uniform per-division loss as the effective loss per division.\n\nReport your final result as two numbers in the order: (number of repeats, number of divisions). Round each value to three significant figures. Do not include units in your final reported numbers.", "solution": "The problem statement submitted for analysis is valid. It is scientifically grounded in established principles of molecular biology, specifically telomere structure and the end-replication problem. It is self-contained, providing all necessary definitions, constants, and a clear mathematical model for telomere shortening. The questions are well-posed, unambiguous, and admit a unique solution based on the provided data. We will now proceed with a formal derivation.\n\nThe problem is divided into two parts. First, we must calculate the number of hexanucleotide repeats in a telomere of a given length. Second, we must estimate the number of cell divisions required for the telomere to shorten by a specified amount, based on a probabilistic model of per-division loss.\n\nPart 1: Calculation of the Number of Repeats.\nLet `$L_{total}$` be the total length of the double-stranded telomere. The problem states `$L_{total} = 10\\ \\mathrm{kb}$`.\nWe are given the conversion factor `$1\\ \\mathrm{kb} = 10^{3}\\ \\mathrm{bp}$`. Therefore, we convert the total length into base pairs (bp):\n$$L_{total} = 10\\ \\mathrm{kb} \\times \\frac{10^{3}\\ \\mathrm{bp}}{1\\ \\mathrm{kb}} = 10 \\times 10^{3}\\ \\mathrm{bp} = 10^{4}\\ \\mathrm{bp}$$\nThe telomere is composed of tandem repeats of the sequence `TTAGGG`. The length contribution of each repeat to the double-stranded tract is given as `$L_{repeat} = 6\\ \\mathrm{bp}$`.\nThe total number of repeats, which we will denote as `$N_{repeats}$`, is the total length of the telomere divided by the length of a single repeat. The problem specifies that subtelomeric regions and the `$3^{\\prime}$` overhang are to be neglected, so we can treat the entire length as being composed of these repeats.\n$$N_{repeats} = \\frac{L_{total}}{L_{repeat}}$$\nSubstituting the values:\n$$N_{repeats} = \\frac{10^{4}\\ \\mathrm{bp}}{6\\ \\mathrm{bp}} = \\frac{10000}{6} = 1666.666...$$\nThe problem requires the final answer to be rounded to three significant figures. This value is `$1.67 \\times 10^3$`.\n\nPart 2: Estimation of the Number of Cell Divisions for Telomere Shortening.\nLet `$\\Delta L_{target}$` be the target amount of shortening for the double-stranded telomere. The problem states this is `$2\\ \\mathrm{kb}$`.\nFirst, we convert this length into base pairs:\n$$\\Delta L_{target} = 2\\ \\mathrm{kb} \\times \\frac{10^{3}\\ \\mathrm{bp}}{1\\ \\mathrm{kb}} = 2 \\times 10^{3}\\ \\mathrm{bp} = 2000\\ \\mathrm{bp}$$\nThe shortening per division is described as a random variable, `$X$`, that is independent for each division and follows a uniform distribution. The range of this distribution is from a minimum loss of `$a = 50\\ \\mathrm{bp}$` to a maximum loss of `$b = 100\\ \\mathrm{bp}$`. This is denoted as `$X \\sim U(a, b)$` or `$X \\sim U(50, 100)$`.\n\nThe problem instructs us to use the expected value of this per-division loss as the effective loss per division to estimate the number of divisions. For a continuous uniform distribution on the interval `$[a, b]$`, the expected value, `$E[X]$`, is given by the formula:\n$$E[X] = \\frac{a+b}{2}$$\nLet us denote the expected loss per division as `$\\Delta L_{div}$`.\n$$\\Delta L_{div} = E[X] = \\frac{50\\ \\mathrm{bp} + 100\\ \\mathrm{bp}}{2} = \\frac{150\\ \\mathrm{bp}}{2} = 75\\ \\mathrm{bp}$$\nThe estimated number of cell divisions, `$N_{div}$`, required to achieve the target shortening is the total target shortening divided by the expected shortening per division.\n$$N_{div} = \\frac{\\Delta L_{target}}{\\Delta L_{div}}$$\nSubstituting the calculated values:\n$$N_{div} = \\frac{2000\\ \\mathrm{bp}}{75\\ \\mathrm{bp}} = \\frac{80}{3} = 26.666...$$\nRounding this value to three significant figures gives `$26.7$`.\n\nThus, the two requested quantities are the number of repeats, approximately `$1.67 \\times 10^3$`, and the expected number of divisions, approximately `$26.7$`. The results are presented in the specified order.", "answer": "$$\\boxed{\\begin{pmatrix} 1.67 \\times 10^3 & 26.7 \\end{pmatrix}}$$", "id": "2609545"}, {"introduction": "Natural chromosome ends are not simply left exposed to the cell's DNA damage machinery; they are actively protected by the shelterin complex. This practice [@problem_id:2609532] challenges you to move beyond a simple list of components and deduce the distinct, non-redundant functions of its core proteins—TRF1, TRF2, and POT1. By predicting the specific cellular phenotypes that arise from depleting each factor, you will gain a deeper appreciation for how shelterin orchestrates a multi-pronged defense, selectively suppressing different DNA damage signaling pathways to maintain genomic stability.", "problem": "An investigator uses an auxin-inducible degron to acutely deplete, in otherwise isogenic human telomerase-positive cells, either telomeric repeat binding factor 1 (TRF1), telomeric repeat binding factor 2 (TRF2), or protection of telomeres 1 (POT1) for a single cell cycle. After depletion, the investigator assesses telomere dysfunction-induced foci (TIFs; defined as the co-localization of DNA damage response markers with telomere signals), metaphase end-to-end chromosome fusions, and “fragile telomeres” (manifested as multiple telomeric fluorescence in situ hybridization (FISH) signals on a single chromatid).\n\nUsing the following fundamental bases:\n- Double-strand DNA ends activate ataxia-telangiectasia mutated (ATM) signaling and recruit canonical non-homologous end joining (c-NHEJ), which can ligate exposed double-stranded ends and produce end-to-end fusions. Single-stranded DNA coated by replication protein A (RPA), typically arising at stalled replication forks or resected ends, activates ataxia-telangiectasia and Rad3 related (ATR) signaling.\n- TRF2 promotes and stabilizes the telomeric t-loop, thereby sequestering the chromosome end away from ATM and suppressing c-NHEJ at telomeres. TRF1 facilitates efficient telomere replication, preventing fork stalling and minimizing RPA-coated single-stranded DNA at telomeres. POT1, in complex with TPP1, binds the $3^{\\prime}$ single-stranded telomeric overhang, displacing RPA and thereby suppressing ATR signaling at chromosome ends.\n\nWhich option best predicts the dominant phenotypic consequences and signaling/repair pathways upon acute depletion of each factor?\n\nA. TRF1 depletion primarily causes ATR-driven TIFs and “fragile telomeres” owing to replication stress and RPA loading at telomeric forks, with minimal end-to-end fusions if TRF2 remains intact; TRF2 depletion exposes chromosome ends, triggering ATM-driven TIFs and robust DNA-dependent protein kinase catalytic subunit (DNA-PKcs)/Ligase IV-dependent c-NHEJ telomere-telomere fusions; POT1 depletion permits RPA binding to the single-stranded overhang, eliciting ATR-driven TIFs and increased single-stranded overhang length, with infrequent fusions unless c-NHEJ is otherwise derepressed.\n\nB. TRF1 depletion exposes chromosome ends, activating ATM and c-NHEJ to produce abundant telomere fusions, whereas TRF2 depletion mainly yields ATR activation and “fragile telomeres”; POT1 depletion produces ATR-independent TIFs dominated by ATM.\n\nC. Acute depletion of any one of TRF1, TRF2, or POT1 yields indistinguishable ATM-driven TIFs and high-frequency c-NHEJ telomere fusions, because all three proteins primarily suppress ATM by promoting t-loop formation.\n\nD. POT1 depletion primarily collapses the t-loop, provoking ATM activation and extensive c-NHEJ-mediated fusions; TRF2 depletion mainly causes replication fork stalling at telomeres with ATR activation and “fragile telomeres”; TRF1 depletion has no immediate effect on replication and instead increases homologous recombination-mediated telomere fusions.\n\nSelect the single best option.", "solution": "The problem statement is subjected to validation prior to any attempt at a solution.\n\n**Step 1: Extraction of Givens**\n\nThe problem provides the following experimental setup and fundamental principles:\n- **System:** Isogenic human telomerase-positive cells.\n- **Intervention:** Acute depletion, via auxin-inducible degron for a single cell cycle, of one of the following proteins:\n    - Telomeric repeat binding factor 1 (TRF1)\n    - Telomeric repeat binding factor 2 (TRF2)\n    - Protection of telomeres 1 (POT1)\n- **Measured Outcomes:**\n    - Telomere dysfunction-induced foci (TIFs)\n    - Metaphase end-to-end chromosome fusions\n    - “Fragile telomeres”\n- **Fundamental Bases (Principles):**\n    - Principle $1$: Double-strand DNA ends activate ataxia-telangiectasia mutated (ATM) signaling and recruit canonical non-homologous end joining (c-NHEJ), which causes end-to-end fusions.\n    - Principle $2$: Single-stranded DNA coated by replication protein A (RPA) activates ataxia-telangiectasia and Rad3 related (ATR) signaling.\n    - Principle $3$ (**TRF2 function**): TRF2 promotes and stabilizes the telomeric t-loop, sequestering the chromosome end to suppress ATM and c-NHEJ.\n    - Principle $4$ (**TRF1 function**): TRF1 facilitates efficient telomere replication, preventing fork stalling and minimizing RPA-coated single-stranded DNA.\n    - Principle $5$ (**POT1 function**): POT1 binds the $3^{\\prime}$ single-stranded telomeric overhang, displacing RPA to suppress ATR signaling.\n\n**Step 2: Validation of Problem Statement**\n\nThe problem is evaluated against criteria for scientific validity and well-posedness.\n- **Scientific Grounding:** The problem is based on established principles of telomere biology. The proteins TRF1, TRF2, and POT1 are core components of the shelterin complex. Their described functions and the roles of ATM, ATR, and c-NHEJ are consistent with current understanding in the field of molecular and cellular biology. The experimental design is standard and plausible.\n- **Well-Posedness:** The problem provides a closed system of rules (the \"Fundamental Bases\") and asks for a logical deduction of outcomes based on these rules. The question is unambiguous and a unique solution can be derived from the provided premises.\n- **Objectivity:** The language is formal, precise, and devoid of subjective or non-scientific terms.\n\n**Step 3: Verdict**\n\nThe problem statement is **valid**. It is a well-posed, scientifically grounded problem that requires logical application of given biological principles. Proceeding to solution derivation.\n\n**Solution Derivation**\n\nWe will deduce the consequences of depleting each protein by strictly applying the given principles.\n\n**1. Consequence of TRF1 Depletion:**\nAccording to Principle $4$, TRF1 facilitates efficient telomere replication and prevents fork stalling. Its depletion will therefore cause replication fork stalling at telomeres. This will generate abnormal DNA structures, specifically an accumulation of single-stranded DNA that becomes coated by RPA. According to Principle $2$, RPA-coated single-stranded DNA activates ATR signaling. This activation of the DNA damage response at telomeres manifests as ATR-driven TIFs. The underlying replication defect is observed cytologically as “fragile telomeres.” Since TRF2 function is unimpaired, Principle $3$ holds: the t-loop structure remains intact, chromosome ends are protected from ATM and c-NHEJ. Consequently, end-to-end chromosome fusions, which are a product of c-NHEJ, should be minimal.\n\n**2. Consequence of TRF2 Depletion:**\nAccording to Principle $3$, TRF2 is essential for stabilizing the t-loop, which physically hides the double-stranded DNA end of the chromosome. Its depletion leads to the “un-capping” of the telomere, exposing a free double-strand DNA end. According to Principle $1$, such an end is recognized as a DNA double-strand break. This activates ATM signaling, leading to ATM-driven TIFs. Furthermore, the ATM pathway recruits the c-NHEJ machinery. C-NHEJ will then ligate these exposed telomeric ends to other DNA breaks or other exposed telomeres, resulting in robust formation of end-to-end chromosome fusions. The c-NHEJ pathway depends on key factors including the DNA-dependent protein kinase catalytic subunit (DNA-PKcs) and DNA Ligase IV.\n\n**3. Consequence of POT1 Depletion:**\nAccording to Principle $5$, POT1 binds to the $3^{\\prime}$ single-stranded G-rich overhang of the telomere, preventing RPA from binding. Its depletion leaves the overhang exposed to RPA. According to Principle $2$, the resulting RPA-coated single-stranded DNA activates ATR signaling, which leads to ATR-driven TIFs. Because TRF2 is present and functional, the t-loop remains stable and the double-stranded end is protected. Therefore, ATM and c-NHEJ are not activated, and chromosome fusions should be infrequent. The loss of POT1 can also lead to deregulation of overhang processing, often observed as an increase in its length, but the primary signaling consequence is ATR activation.\n\n**Evaluation of Options**\n\nWe now evaluate each option against our derived conclusions.\n\n**A.**\n- **TRF1 depletion:** `...causes ATR-driven TIFs and “fragile telomeres” owing to replication stress and RPA loading... with minimal end-to-end fusions...` This is fully consistent with our derivation.\n- **TRF2 depletion:** `...exposes chromosome ends, triggering ATM-driven TIFs and robust DNA-dependent protein kinase catalytic subunit (DNA-PKcs)/Ligase IV-dependent c-NHEJ telomere-telomere fusions.` This is fully consistent with our derivation and correctly identifies key c-NHEJ components.\n- **POT1 depletion:** `...permits RPA binding to the single-stranded overhang, eliciting ATR-driven TIFs and increased single-stranded overhang length, with infrequent fusions...` This is fully consistent with our derivation.\n**Verdict: Correct.**\n\n**B.**\n- `TRF1 depletion exposes chromosome ends, activating ATM and c-NHEJ...` This is incorrect. It wrongly attributes the function of TRF2 (preventing end exposure) to TRF1.\n- `...TRF2 depletion mainly yields ATR activation and “fragile telomeres”` This is incorrect. It wrongly attributes the consequences of TRF1 depletion to TRF2 depletion.\n**Verdict: Incorrect.**\n\n**C.**\n- `...depletion of any one of TRF1, TRF2, or POT1 yields indistinguishable ATM-driven TIFs and high-frequency c-NHEJ telomere fusions...` This is incorrect. The principles provided dictate distinct outcomes. TRF1 and POT1 depletion primarily activate ATR, while TRF2 depletion activates ATM. High-frequency fusions are characteristic only of TRF2 depletion.\n- `...because all three proteins primarily suppress ATM by promoting t-loop formation.` This premise is incorrect. Only TRF2 is assigned this role by the given principles.\n**Verdict: Incorrect.**\n\n**D.**\n- `POT1 depletion primarily collapses the t-loop, provoking ATM activation and extensive c-NHEJ-mediated fusions;` This is incorrect. It wrongly attributes the function of TRF2 to POT1.\n- `TRF2 depletion mainly causes replication fork stalling at telomeres with ATR activation...` This is incorrect. It wrongly attributes the consequences of TRF1 depletion to TRF2.\n- `TRF1 depletion has no immediate effect on replication...` This directly contradicts Principle $4$.\n**Verdict: Incorrect.**\n\nBased on this systematic analysis, option A is the only statement that accurately describes the consequences of depleting each protein in accordance with the provided fundamental principles.", "answer": "$$\\boxed{A}$$", "id": "2609532"}, {"introduction": "While we have explored telomere attrition and protection as distinct processes, in a living cell they are opposing forces in a dynamic equilibrium that establishes a homeostatic length. This exercise [@problem_id:2609476] introduces a powerful approach from mathematical biology, using a first-order differential equation to model telomere length homeostasis. By analyzing the steady-state solution and its stability, you will formalize the concept of a telomere length \"set point\" and discover the critical conditions required for a cell to maintain its telomeres at a stable, finite length over time.", "problem": "A single-cell lineage maintains telomere length through a balance between sequence loss during Deoxyribonucleic Acid (DNA) replication and sequence addition by telomerase. Suppose the mean telomere length $L(t)$ in base pairs evolves as a first-order deterministic dynamical system with negative feedback on telomerase activity as telomeres lengthen. Let the governing equation be\n$$\n\\frac{dL}{dt} \\;=\\; \\frac{a}{1 + b L} \\;-\\; c,\n$$\nwhere $a>0$ is the maximal effective rate of telomeric repeat addition at very short telomeres, $b \\ge 0$ quantifies the strength of length-dependent inhibition of telomerase action (for example, via shelterin occupancy), and $c>0$ is the effective mean rate of telomere loss per unit time from end-replication and nucleolytic processing. Assume that $L(t)$ is restricted to the biologically meaningful domain $L \\ge 0$.\n\nStarting from the core definitions of steady state (time derivative equal to zero) and local asymptotic stability for one-dimensional autonomous systems (sign of the derivative of the right-hand side at the fixed point), carry out the following:\n\n- Derive a closed-form expression for the positive steady-state telomere length $L^{\\ast}$, if it exists, as a function of $a$, $b$, and $c$.\n- Determine the parameter conditions on $a$, $b$, and $c$ under which a positive steady state exists and is locally asymptotically stable, ensuring there are no singularities in the positive domain.\n\nProvide your final answer as the closed-form expression for $L^{\\ast}$ in terms of $a$, $b$, and $c$. No numerical approximation is required, and no units should be included in the final expression.", "solution": "The problem presents a first-order autonomous ordinary differential equation to model the dynamics of mean telomere length, $L(t)$. The governing equation is given as:\n$$\n\\frac{dL}{dt} = \\frac{a}{1 + b L} - c\n$$\nThe parameters are defined with constraints: $a > 0$, $b \\ge 0$, and $c > 0$. The domain of the state variable $L$ is restricted to be non-negative, $L \\ge 0$, which is biologically necessary. The task is to find the positive steady-state telomere length, denoted as $L^{\\ast}$, and determine the conditions under which it exists and is locally asymptotically stable.\n\nFirst, we validate the problem formulation. The equation represents a standard negative feedback model, where the rate of telomere addition, $\\frac{a}{1 + bL}$, decreases as length $L$ increases, opposed by a constant rate of loss, $c$. This is a well-established and scientifically sound approach in mathematical biology for modeling such regulatory systems. The function on the right-hand side, let us call it $f(L) = \\frac{a}{1 + bL} - c$, is well-behaved on the domain of interest. For $L \\ge 0$ and $b \\ge 0$, the denominator $1 + bL$ is always greater than or equal to $1$, so there are no singularities in the physical domain. The problem is self-contained, objective, and well-posed. Thus, we proceed with the analysis.\n\nA steady state, or fixed point, $L^{\\ast}$, is a value of $L$ for which the system ceases to evolve. Mathematically, this corresponds to the condition where the time derivative is zero:\n$$\n\\frac{dL}{dt} \\bigg|_{L=L^{\\ast}} = 0\n$$\nSubstituting the governing equation, we get:\n$$\n\\frac{a}{1 + b L^{\\ast}} - c = 0\n$$\nWe must now solve this algebraic equation for $L^{\\ast}$.\n$$\n\\frac{a}{1 + b L^{\\ast}} = c\n$$\nAssuming $c > 0$, we can manipulate the equation:\n$$\na = c(1 + b L^{\\ast})\n$$\n$$\na = c + cb L^{\\ast}\n$$\n$$\na - c = cb L^{\\ast}\n$$\nTo find the expression for $L^{\\ast}$, we must consider the case for the parameter $b$. The problem states $b \\ge 0$.\n\nCase 1: $b > 0$.\nIn this case, we can divide by $cb$ (since $c > 0$ and $b > 0$, $cb \\neq 0$):\n$$\nL^{\\ast} = \\frac{a-c}{cb}\n$$\nThe problem demands a *positive* steady state, so we require $L^{\\ast} > 0$. Since the denominator $cb$ is positive, the sign of $L^{\\ast}$ is determined by the sign of the numerator, $a-c$. For $L^{\\ast} > 0$, we must have:\n$$\na - c > 0 \\implies a > c\n$$\nThus, a unique positive steady state exists if and only if $b > 0$ and $a > c$. The interpretation is that the maximal rate of telomere addition must exceed the rate of loss for a stable, positive length to be maintained.\n\nCase 2: $b = 0$.\nIf $b=0$, the governing equation becomes:\n$$\n\\frac{dL}{dt} = \\frac{a}{1 + (0) L} - c = a - c\n$$\nFor a steady state to exist, we must have $\\frac{dL}{dt} = 0$, which implies $a - c = 0$, or $a = c$. If this condition holds, then $\\frac{dL}{dt} = 0$ for all values of $L$. This is a degenerate case where every possible length is a steady state, not a unique positive one. If $a \\ne c$, no steady state exists. Therefore, the condition $b > 0$ is necessary for the existence of a unique steady state as described.\n\nNext, we analyze the local asymptotic stability of the positive steady state $L^{\\ast} = \\frac{a-c}{cb}$, which exists when $a > c$ and $b > 0$. For a one-dimensional autonomous system $\\frac{dL}{dt} = f(L)$, a fixed point $L^{\\ast}$ is locally asymptotically stable if the derivative of $f(L)$ evaluated at $L^{\\ast}$ is negative, i.e., $f'(L^{\\ast}) < 0$.\n\nLet's compute the derivative of $f(L) = a(1+bL)^{-1} - c$ with respect to $L$:\n$$\nf'(L) = \\frac{d}{dL} \\left( \\frac{a}{1+bL} - c \\right) = a \\cdot (-1)(1+bL)^{-2} \\cdot \\frac{d}{dL}(1+bL) = -ab(1+bL)^{-2}\n$$\nSo, the derivative is:\n$$\nf'(L) = -\\frac{ab}{(1+bL)^2}\n$$\nNow, we evaluate this derivative at the steady state $L^{\\ast}$. However, we can determine the sign of $f'(L)$ for any $L$ in the domain $L \\ge 0$.\nGiven $a > 0$ and the condition $b > 0$, the numerator $ab$ is strictly positive.\nThe denominator $(1+bL)^2$ is the square of a real number and is always positive for any $L$ in its domain (it is $1$ at $L=0$ and greater for $L>0$).\nTherefore, for any $L \\ge 0$:\n$$\nf'(L) = -\\frac{ab}{(1+bL)^2} = -\\frac{\\text{(positive number)}}{\\text{(positive number)}} < 0\n$$\nSince $f'(L)$ is strictly negative for all $L \\ge 0$ (under the conditions $a>0, b>0$), it is also strictly negative at the specific point $L=L^{\\ast}$.\n$$\nf'(L^{\\ast}) < 0\n$$\nThis confirms that whenever the positive steady state $L^{\\ast}$ exists (i.e., when $a > c$ and $b > 0$), it is always locally asymptotically stable. The system will always return to this equilibrium length after small perturbations.\n\nIn summary:\n1. A positive steady-state telomere length $L^{\\ast}$ exists if and only if the rate of addition can overcome the rate of loss ($a > c$) and there is a length-dependent inhibition mechanism ($b > 0$).\n2. Under these conditions, the steady state is given by $L^{\\ast} = \\frac{a-c}{cb}$.\n3. This steady state is always locally asymptotically stable because the negative feedback term ensures that $f'(L) < 0$ for all biologically relevant lengths $L \\ge 0$.\n\nThe problem asks for the closed-form expression for $L^{\\ast}$. This expression is derived under the necessary conditions for its existence as a positive, unique steady state.", "answer": "$$\n\\boxed{\\frac{a-c}{cb}}\n$$", "id": "2609476"}]}